These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 19606173
1. Possible effect of systemic sympathicolytic drugs on apraclonidine test. Martín-Moro JG, Botín DM, Muñoz-Negrete FJ. Can J Ophthalmol; 2009 Aug; 44(4):463; author reply 463-4. PubMed ID: 19606173 [No Abstract] [Full Text] [Related]
2. False-negative apraclonidine testing in acute Horner syndrome. Dewan MA, Harrison AR, Lee MS. Can J Ophthalmol; 2009 Feb; 44(1):109-10. PubMed ID: 19169332 [No Abstract] [Full Text] [Related]
3. But it's not all there. Peterson JD, Bilyk JR, Sergott RC. Surv Ophthalmol; 2013 Feb; 58(5):492-9. PubMed ID: 22784676 [Abstract] [Full Text] [Related]
12. Comparing efficacies of 0.5% apraclonidine with 4% cocaine in the diagnosis of horner syndrome in pediatric patients. Chen PL, Chen JT, Lu DW, Chen YC, Hsiao CH. J Ocul Pharmacol Ther; 2006 Jun; 22(3):182-7. PubMed ID: 16808679 [Abstract] [Full Text] [Related]
13. Positive apraclonidine test 36 hours after acute onset of horner syndrome in dorsolateral pontomedullary stroke. Lebas M, Seror J, Debroucker T. J Neuroophthalmol; 2010 Mar; 30(1):12-7. PubMed ID: 20182200 [Abstract] [Full Text] [Related]
14. Topical apraclonidine to diagnose Bernard-Horner syndrome. Kocabora M, Gocmez E, Taskapili M. Bull Soc Belge Ophtalmol; 2009 Mar; (312):9-15. PubMed ID: 19927485 [Abstract] [Full Text] [Related]
15. Using apraclonidine in diagnosing Horner syndrome in children. Sueke H, Chandna A. Am J Ophthalmol; 2010 May; 149(5):869; author reply 870. PubMed ID: 20399934 [No Abstract] [Full Text] [Related]
16. The utility of 0.5% apraclonidine in the diagnosis of horner syndrome. Brown SM. Arch Ophthalmol; 2005 Apr; 123(4):578; author reply 578. PubMed ID: 15824244 [No Abstract] [Full Text] [Related]
17. Topical apraclonidine in the diagnosis of suspected Horner syndrome. Freedman KA, Brown SM. J Neuroophthalmol; 2005 Jun; 25(2):83-5. PubMed ID: 15937427 [Abstract] [Full Text] [Related]
18. The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis. Koc F, Kavuncu S, Kansu T, Acaroglu G, Firat E. Br J Ophthalmol; 2005 Nov; 89(11):1442-4. PubMed ID: 16234449 [Abstract] [Full Text] [Related]
19. Effect of 0.5% apraclonidine on ptosis in Horner syndrome. Garibaldi DC, Hindman HB, Grant MP, Iliff NT, Merbs SL. Ophthalmic Plast Reconstr Surg; 2006 Nov; 22(1):53-5. PubMed ID: 16418668 [Abstract] [Full Text] [Related]
20. Congenital Horner's syndrome and the usefulness of the apraclonidine test in its diagnosis. Mirzai H, Baser EF. Indian J Ophthalmol; 2006 Sep; 54(3):197-9. PubMed ID: 16921219 [Abstract] [Full Text] [Related] Page: [Next] [New Search]